Physician profile
Toby A Rockefeller
NPI 1265662241
$6,597.88
in general payments reported to CMS, 2019-2025
13 companies · $693 in 2025
The $693 reported for 2025 was more than what 75% of Pediatric Cardiology providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $787 · 2020: $828 · 2021: $703 · 2022: $888 · 2023: $1,849 · 2024: $849 · 2025: $693.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,488 · Travel and Lodging: $904.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,487.97 |
| Travel and Lodging | $903.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,955.94 | 2019-2025 | Amplatzer Piccolo, Amplatzer, Cardiomems |
| Medtronic, INC. | $1,463.62 | 2021-2024 | Harmony |
| Siemens Medical Solutions USA, INC. | $711.36 | 2020 | |
| Medtronic Vascular, INC. | $603.96 | 2019-2020 | |
| Penumbra, INC. | $403.68 | 2024-2025 | Ruby Coil, Penumbra System, Indigo System |
| W. L. Gore & Associates, INC. | $242.55 | 2019-2024 | Gore Cardioform Septal Occluder |
| B. Braun Interventional Systems INC. | $66.74 | 2019-2022 | |
| Canon Medical Systems USA, INC. | $60.33 | 2020 | |
| Novartis Pharmaceuticals Corporation | $32.64 | 2024-2025 | |
| Novo Nordisk INC | $19.33 | 2025 | Wegovy |
| Amgen INC. | $14.85 | 2024 | |
| Kiniksa Pharmaceuticals International, Plc | $14.49 | 2024 | Arcalyst |
| Z-Medica, LLC | $8.39 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Toby Rockefeller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.